|
|
OTC Healthcare in Norway to 2013
|
|||||||||||
| Preis** (Lieferformat): |
Versandkostenfrei ** WICHTIG: Alle Preise sind netto ausgewiesen. Abhängig von Versand- und Leistungsort ist hierauf noch USt. zu entrichten (Deutschland z.Z. 19%). Der korrekte Gesamtendpreis wird Ihnen mit der Angabe Ihrer Rechnungsadresse, USt-ID-Nr. etc. im Bestellverlauf ausgewiesen. Weitere Informationen zu den Bestandteilen des Kaufpreises finden Sie in unseren FAQs. |
Zahlen und Fakten zur Studie: | 189 seiten | |||||||||
| Inhalt der Studie: |
Introduction
This databook provides key data and information on the OTC healthcare market in Norway. This report is a comprehensive resource for market, category and segment level data including valu.....
Introduction This databook provides key data and information on the OTC healthcare market in Norway. This report is a comprehensive resource for market, category and segment level data including value, distribution share and company & brand share. Scope *Contains information on:analgesics,medicated skin product,topical OTC,traditional,indigestion,cough&cold,plasters&Bandages,vitamins and first aid kits *Market,category and segment level information on value with historic (2003-2008) and forecast (2009-2013) data *Category level company and brand share as well as distribution share information for 2007 and 2008 *Review of the top two companies within the OTC healthcare market, including company overview, key facts and business description Highlights The market for OTC healthcare in Norway increased at a compound annual growth rate of 4.1% between 2003 and 2008. The analgesics category led the OTC healthcare market in Norway, accounting for a share of 19.5%. Leading players in Norwegian OTC healthcare market include Johnson & Johnson, Novartis AG and GlaxoSmithKline Plc. Reasons to Purchase *Develop business strategies by understanding the quantitative trends within the OTC healthcare market in Norway *Design effective marketing and sales strategies by identifying key market categories and segments *Identify key players within the market to plan lucrative M&A, partnerships and agreements Report Highlights [Studien Infos ausblenden] |
|||||||||||
|
TABLE OF CONTENTS Chapter 1 Executive Summary 2 Summary market level: OTC healthcare 2 Summary category level: analgesics 3 Summary category level: topical OTC medicines 4 Summary category level: cough and cold preparations 5 Summary category level: indigestion preparations 6 Summary category level: medicated skin products 7 Summary category level: first aid kits 8 Summary category level: other OTC healthcare products 9 Summary category level: plasters & bandages 10 Summary category level: traditional medicines 11 Summary category level: vitamins and minerals 12 Chapter 2 Introduction 13 What is this report about? 13 How to use this report 13 Market definition 14 Chapter 3 Market Overview 30 Value analysis (Norwegian Krone), 2003?08 30 Value analysis (Norwegian Krone), 2008?13 32 Value analysis (US dollars), 2003?08 34 Value analysis (US dollars), 2008?13 35 Company and brand share analysis 37 Distribution analysis 44 Chapter 4 Leading Company Profiles 46 Johnson & Johnson 46 Novartis AG 48 Chapter 5 Category Analysis: Analgesics 50 Value analysis (Norwegian Krone), 2003?08 50 Value analysis (Norwegian Krone), 2008?13 51 Value analysis (US dollars), 2003?08 53 Value analysis (US dollars), 2008?13 53 Company and brand share analysis 55 Distribution analysis 58 Chapter 6 Category Analysis: Topical OTC Medicines 60 Value analysis (Norwegian Krone), 2003?08 60 Value analysis (Norwegian Krone), 2008?13 61 Value analysis (US dollars), 2003?08 63 Value analysis (US dollars), 2008?13 64 Company and brand share analysis 66 Distribution analysis 69 Chapter 7 Category Analysis: Cough and Cold Preparations 71 Value analysis (Norwegian Krone), 2003?08 71 Value analysis (Norwegian Krone), 2008?13 72 Value analysis (US dollars), 2003?08 74 Value analysis (US dollars), 2008?13 75 Company and brand share analysis 77 Distribution analysis 80 Chapter 8 Category Analysis: Indigestion Preparations 82 Value analysis (Norwegian Krone), 2003?08 82 Value analysis (Norwegian Krone), 2008?13 83 Value analysis (US dollars), 2003?08 85 Value analysis (US dollars), 2008?13 85 Company and brand share analysis 87 Distribution analysis 90 Chapter 9 Category Analysis: Medicated Skin Products 92 Value analysis (Norwegian Krone), 2003?08 92 Value analysis (Norwegian Krone), 2008?13 93 Value analysis (US dollars), 2003?08 95 Value analysis (US dollars), 2008?13 96 Company and brand share analysis 98 Distribution analysis 101 Chapter 10 Category Analysis: First Aid Kits 103 Value analysis (Norwegian Krone), 2003?08 103 Value analysis (Norwegian Krone), 2008?13 104 Value analysis (US dollars), 2003?08 105 Value analysis (US dollars), 2008?13 105 Company and brand share analysis 106 Distribution analysis 109 Chapter 11 Category Analysis: Other OTC Healthcare Products 111 Value analysis (Norwegian Krone), 2003?08 111 Value analysis (Norwegian Krone), 2008?13 112 Value analysis (US dollars), 2003?08 114 Value analysis (US dollars), 2008?13 115 Company and brand share analysis 117 Distribution analysis 121 Chapter 12 Category Analysis: Plasters & Bandages 123 Value analysis (Norwegian Krone), 2003?08 123 Value analysis (Norwegian Krone), 2008?13 124 Value analysis (US dollars), 2003?08 126 Value analysis (US dollars), 2008?13 127 Company and brand share analysis 129 Distribution analysis 134 Chapter 13 Category Analysis: Traditional Medicines 136 Value analysis (Norwegian Krone), 2003?08 136 Value analysis (Norwegian Krone), 2008?13 137 Value analysis (US dollars), 2003?08 138 Value analysis (US dollars), 2008?13 138 Company and brand share analysis 139 Distribution analysis 142 Chapter 14 Category Analysis: Vitamins and Minerals 144 Value analysis (Norwegian Krone), 2003?08 144 Value analysis (Norwegian Krone), 2008?13 145 Value analysis (US dollars), 2003?08 147 Value analysis (US dollars), 2008?13 147 Company and brand share analysis 149 Distribution analysis 152 Chapter 15 Country Comparison 154 Value 154 Market share 158 Chapter 16 PESTLE Analysis 159 Summary 159 Political analysis 160 Economic analysis 163 Social analysis 166 Technological analysis 169 Legal analysis 172 Environmental analysis 174 Chapter 17 New Product Development 177 Product launches over time 177 Recent product launches 179 Chapter 18 Macroeconomic Profile 180 Macroeconomic indicators 180 Chapter 19 Research Methodology 185 Methodology overview 185 Secondary research 186 Market modeling 187 Creating an initial data model 187 Revising the initial data model 187 Creating a final estimate 188 Creating demographic value splits 188 Primary research 188 Data finalization 189 Ongoing research 189 Chapter 20 APPENDIX 190 Future readings 190 How to contact experts in your industry 190 Disclaimer 190 LIST OF FIGURES Figure 1: Norway OTC healthcare value and value forecast, 2003?13 (NOKm, nominal prices) 33 Figure 2: Norway OTC healthcare category growth comparison, by value, 2003?13 36 Figure 3: Norway OTC healthcare company share, by value, 2007?08 (%) 41 Figure 4: Norway OTC healthcare distribution channels, by value, 2007?08 (%) 45 Figure 5: Norway analgesics value and value forecast, 2003?13 (NOKm, nominal prices) 52 Figure 6: Norway analgesics category growth comparison, by value, 2003?13 54 Figure 7: Norway analgesics company share, by value, 2007?08 (%) 56 Figure 8: Norway analgesics distribution channels, by value, 2007?08 (%) 59 Figure 9: Norway topical OTC medicines value and value forecast, 2003?13 (NOKm, nominal prices) 62 Figure 10: Norway topical OTC medicines category growth comparison, by value, 2003?13 65 Figure 11: Norway topical OTC medicines company share, by value, 2007?08 (%) 67 Figure 12: Norway topical OTC medicines distribution channels, by value, 2007?08 (%) 70 Figure 13: Norway cough and cold preparations value and value forecast, 2003?13 (NOKm, nominal prices) 73 Figure 14: Norway cough and cold preparations category growth comparison, by value, 2003?13 76 Figure 15: Norway cough and cold preparations company share, by value, 2007?08 (%) 78 Figure 16: Norway cough and cold preparations distribution channels, by value, 2007?08 (%) 81 Figure 17: Norway indigestion preparations value and value forecast, 2003?13 (NOKm, nominal prices) 84 Figure 18: Norway indigestion preparations category growth comparison, by value, 2003?13 86 Figure 19: Norway indigestion preparations company share, by value, 2007?08 (%) 88 Figure 20: Norway indigestion preparations distribution channels, by value, 2007?08 (%) 91 Figure 21: Norway medicated skin products value and value forecast, 2003?13 (NOKm, nominal prices) 94 Figure 22: Norway medicated skin products category growth comparison, by value, 2003?13 97 Figure 23: Norway medicated skin products company share, by value, 2007?08 (%) 99 Figure 24: Norway medicated skin products distribution channels, by value, 2007?08 (%) 102 Figure 25: Norway first aid kits value and value forecast, 2003?13 (NOKm, nominal prices) 104 Figure 26: Norway first aid kits company share, by value, 2007?08 (%) 107 Figure 27: Norway first aid kits distribution channels, by value, 2007?08 (%) 110 Figure 28: Norway other OTC healthcare products value and value forecast, 2003?13 (NOKm, nominal prices) 113 Figure 29: Norway other OTC healthcare products category growth comparison, by value, 2003?13 116 Figure 30: Norway other OTC healthcare products company share, by value, 2007?08 (%) 119 Figure 31: Norway other OTC healthcare products distribution channels, by value, 2007?08 (%) 122 Figure 32: Norway plasters & bandages value and value forecast, 2003?13 (NOKm, nominal prices) 125 Figure 33: Norway plasters & bandages category growth comparison, by value, 2003?13 128 Figure 34: Norway plasters & bandages company share, by value, 2007?08 (%) 131 Figure 35: Norway plasters & bandages distribution channels, by value, 2007?08 (%) 135 Figure 36: Norway traditional medicines value and value forecast, 2003?13 (NOKm, nominal prices) 137 Figure 37: Norway traditional medicines company share, by value, 2007?08 (%) 140 Figure 38: Norway traditional medicines distribution channels, by value, 2007?08 (%) 143 Figure 39: Norway vitamins and minerals value and value forecast, 2003?13 (NOKm, nominal prices) 146 Figure 40: Norway vitamins and minerals category growth comparison, by value, 2003?13 148 Figure 41: Norway vitamins and minerals company share, by value, 2007?08 (%) 150 Figure 42: Norway vitamins and minerals distribution channels, by value, 2007?08 (%) 153 Figure 43: Global OTC healthcare market split (value terms, 2008), top five countries 155 Figure 44: Global OTC healthcare market value, 2003–08, top five countries 157 Figure 45: Annual data review process 186 LIST OF TABLES Table 1: OTC healthcare category definitions 15 Table 2: OTC healthcare distribution channels 17 Table 3: Norway OTC healthcare value, 2003?08 (NOKm, nominal prices) 31 Table 4: Norway OTC healthcare value forecast, 2008?13 (NOKm, nominal prices) 32 Table 5: Norway OTC healthcare value, 2003?08 ($m, nominal prices) 34 Table 6: Norway OTC healthcare value forecast, 2008?13 ($m, nominal prices) 35 Table 7: Norway OTC healthcare brand share, by value, 2007?08 (%) 37 Table 8: Norway OTC healthcare value, by brand 2007?08 (NOKm, nominal prices) 39 Table 9: Norway OTC healthcare company share by value, 2007?08 (%) 42 Table 10: Norway OTC healthcare value, by company, 2007?08 (NOKm, nominal prices) 43 Table 11: Norway OTC healthcare distribution channels, by value, 2007?08 (%) 44 Table 12: Norway OTC healthcare value, by distribution channel, 2007?08 (NOKm, nominal prices) 44 Table 13: Johnson & Johnson key facts 46 Table 14: Novartis AG key facts 48 Table 15: Norway analgesics value, 2003?08 (NOKm, nominal prices) 50 Table 16: Norway analgesics value forecast, 2008?13 (NOKm, nominal prices) 51 Table 17: Norway analgesics value, 2003?08 ($m, nominal prices) 53 Table 18: Norway analgesics value forecast, 2008?13 ($m, nominal prices) 53 Table 19: Norway analgesics brand share, by value, 2007?08 (%) 55 Table 20: Norway analgesics value, by brand 2007?08 (NOKm, nominal prices) 55 Table 21: Norway analgesics company share by value, 2007?08 (%) 57 Table 22: Norway analgesics value, by company, 2007?08 (NOKm, nominal prices) 57 Table 23: Norway analgesics distribution channels, by value, 2007?08 (%) 58 Table 24: Norway analgesics value, by distribution channel, 2007?08 (NOKm, nominal prices) 58 Table 25: Norway topical OTC medicines value, 2003?08 (NOKm, nominal prices) 60 Table 26: Norway topical OTC medicines value forecast, 2008?13 (NOKm, nominal prices) 61 Table 27: Norway topical OTC medicines value, 2003?08 ($m, nominal prices) 63 Table 28: Norway topical OTC medicines value forecast, 2008?13 ($m, nominal prices) 64 Table 29: Norway topical OTC medicines brand share, by value, 2007?08 (%) 66 Table 30: Norway topical OTC medicines value, by brand 2007?08 (NOKm, nominal prices) 66 Table 31: Norway topical OTC medicines company share by value, 2007?08 (%) 68 Table 32: Norway topical OTC medicines value, by company, 2007?08 (NOKm, nominal prices) 68 Table 33: Norway topical OTC medicines distribution channels, by value, 2007?08 (%) 69 Table 34: Norway topical OTC medicines value, by distribution channel, 2007?08 (NOKm, nominal prices) 69 Table 35: Norway cough and cold preparations value, 2003?08 (NOKm, nominal prices) 71 Table 36: Norway cough and cold preparations value forecast, 2008?13 (NOKm, nominal prices) 72 Table 37: Norway cough and cold preparations value, 2003?08 ($m, nominal prices) 74 Table 38: Norway cough and cold preparations value forecast, 2008?13 ($m, nominal prices) 75 Table 39: Norway cough and cold preparations brand share, by value, 2007?08 (%) 77 Table 40: Norway cough and cold preparations value, by brand 2007?08 (NOKm, nominal prices) 77 Table 41: Norway cough and cold preparations company share by value, 2007?08 (%) 79 Table 42: Norway cough and cold preparations value, by company, 2007?08 (NOKm, nominal prices) 79 Table 43: Norway cough and cold preparations distribution channels, by value, 2007?08 (%) 80 Table 44: Norway cough and cold preparations value, by distribution channel, 2007?08 (NOKm, nominal prices) 80 Table 45: Norway indigestion preparations value, 2003?08 (NOKm, nominal prices) 82 Table 46: Norway indigestion preparations value forecast, 2008?13 (NOKm, nominal prices) 83 Table 47: Norway indigestion preparations value, 2003?08 ($m, nominal prices) 85 Table 48: Norway indigestion preparations value forecast, 2008?13 ($m, nominal prices) 85 Table 49: Norway indigestion preparations brand share, by value, 2007?08 (%) 87 Table 50: Norway indigestion preparations value, by brand 2007?08 (NOKm, nominal prices) 87 Table 51: Norway indigestion preparations company share by value, 2007?08 (%) 89 Table 52: Norway indigestion preparations value, by company, 2007?08 (NOKm, nominal prices) 89 Table 53: Norway indigestion preparations distribution channels, by value, 2007?08 (%) 90 Table 54: Norway indigestion preparations value, by distribution channel, 2007?08 (NOKm, nominal prices) 90 Table 55: Norway medicated skin products value, 2003?08 (NOKm, nominal prices) 92 Table 56: Norway medicated skin products value forecast, 2008?13 (NOKm, nominal prices) 93 Table 57: Norway medicated skin products value, 2003?08 ($m, nominal prices) 95 Table 58: Norway medicated skin products value forecast, 2008?13 ($m, nominal prices) 96 Table 59: Norway medicated skin products brand share, by value, 2007?08 (%) 98 Table 60: Norway medicated skin products value, by brand 2007?08 (NOKm, nominal prices) 98 Table 61: Norway medicated skin products company share by value, 2007?08 (%) 100 Table 62: Norway medicated skin products value, by company, 2007?08 (NOKm, nominal prices) 100 Table 63: Norway medicated skin products distribution channels, by value, 2007?08 (%) 101 Table 64: Norway medicated skin products value, by distribution channel, 2007?08 (NOKm, nominal prices) 101 Table 65: Norway first aid kits value, 2003?08 (NOKm, nominal prices) 103 Table 66: Norway first aid kits value forecast, 2008?13 (NOKm, nominal prices) 104 Table 67: Norway first aid kits value, 2003?08 ($m, nominal prices) 105 Table 68: Norway first aid kits value forecast, 2008?13 ($m, nominal prices) 105 Table 69: Norway first aid kits brand share, by value, 2007?08 (%) 106 Table 70: Norway first aid kits value, by brand 2007?08 (NOKm, nominal prices) 106 Table 71: Norway first aid kits company share by value, 2007?08 (%) 108 Table 72: Norway first aid kits value, by company, 2007?08 (NOKm, nominal prices) 108 Table 73: Norway first aid kits distribution channels, by value, 2007?08 (%) 109 Table 74: Norway first aid kits value, by distribution channel, 2007?08 (NOKm, nominal prices) 109 Table 75: Norway other OTC healthcare products value, 2003?08 (NOKm, nominal prices) 111 Table 76: Norway other OTC healthcare products value forecast, 2008?13 (NOKm, nominal prices) 112 Table 77: Norway other OTC healthcare products value, 2003?08 ($m, nominal prices) 114 Table 78: Norway other OTC healthcare products value forecast, 2008?13 ($m, nominal prices) 115 Table 79: Norway other OTC healthcare products brand share, by value, 2007?08 (%) 117 Table 80: Norway other OTC healthcare products value, by brand 2007?08 (NOKm, nominal prices) 118 Table 81: Norway other OTC healthcare products company share by value, 2007?08 (%) 120 Table 82: Norway other OTC healthcare products value, by company, 2007?08 (NOKm, nominal prices) 120 Table 83: Norway other OTC healthcare products distribution channels, by value, 2007?08 (%) 121 Table 84: Norway other OTC healthcare products value, by distribution channel, 2007?08 (NOKm, nominal prices) 121 Table 85: Norway plasters & bandages value, 2003?08 (NOKm, nominal prices) 123 Table 86: Norway plasters & bandages value forecast, 2008?13 (NOKm, nominal prices) 124 Table 87: Norway plasters & bandages value, 2003?08 ($m, nominal prices) 126 Table 88: Norway plasters & bandages value forecast, 2008?13 ($m, nominal prices) 127 Table 89: Norway plasters & bandages brand share, by value, 2007?08 (%) 129 Table 90: Norway plasters & bandages value, by brand 2007?08 (NOKm, nominal prices) 130 Table 91: Norway plasters & bandages company share by value, 2007?08 (%) 132 Table 92: Norway plasters & bandages value, by company, 2007?08 (NOKm, nominal prices) 133 Table 93: Norway plasters & bandages distribution channels, by value, 2007?08 (%) 134 Table 94: Norway plasters & bandages value, by distribution channel, 2007?08 (NOKm, nominal prices) 134 Table 95: Norway traditional medicines value, 2003?08 (NOKm, nominal prices) 136 Table 96: Norway traditional medicines value forecast, 2008?13 (NOKm, nominal prices) 137 Table 97: Norway traditional medicines value, 2003?08 ($m, nominal prices) 138 Table 98: Norway traditional medicines value forecast, 2008?13 ($m, nominal prices) 138 Table 99: Norway traditional medicines brand share, by value, 2007?08 (%) 139 Table 100: Norway traditional medicines value, by brand 2007?08 (NOKm, nominal prices) 139 Table 101: Norway traditional medicines company share by value, 2007?08 (%) 141 Table 102: Norway traditional medicines value, by company, 2007?08 (NOKm, nominal prices) 141 Table 103: Norway traditional medicines distribution channels, by value, 2007?08 (%) 142 Table 104: Norway traditional medicines value, by distribution channel, 2007?08 (NOKm, nominal prices) 142 Table 105: Norway vitamins and minerals value, 2003?08 (NOKm, nominal prices) 144 Table 106: Norway vitamins and minerals value forecast, 2008?13 (NOKm, nominal prices) 145 Table 107: Norway vitamins and minerals value, 2003?08 ($m, nominal prices) 147 Table 108: Norway vitamins and minerals value forecast, 2008?13 ($m, nominal prices) 147 Table 109: Norway vitamins and minerals brand share, by value, 2007?08 (%) 149 Table 110: Norway vitamins and minerals value, by brand 2007?08 (NOKm, nominal prices) 149 Table 111: Norway vitamins and minerals company share by value, 2007?08 (%) 151 Table 112: Norway vitamins and minerals value, by company, 2007?08 (NOKm, nominal prices) 151 Table 113: Norway vitamins and minerals distribution channels, by value, 2007?08 (%) 152 Table 114: Norway vitamins and minerals value, by distribution channel, 2007?08 (NOKm, nominal prices) 152 Table 115: Global OTC healthcare market value, 2008 154 Table 116: Global OTC healthcare market split (value terms ($m), 2008), top five countries 157 Table 117: Leading players, top five countries 158 Table 118: Analysis of Norway’s political landscape 160 Table 119: Analysis of Norway’s economic landscape 163 Table 120: Analysis of Norway’s social landscape 166 Table 121: Analysis of Norway’s technology landscape 169 Table 122: Number of patents registered by country 171 Table 123: Analysis of Norway’s legal landscape 172 Table 124: Analysis of Norway’s environmental landscape 174 Table 125: Norway OTC healthcare new product launches reports, by company 2008 177 Table 126: Norway OTC healthcare new product launches SKUs, by company 2008 177 Table 127: Norway OTC healthcare new product launches (reports), by flavor and fragrances 2008 178 Table 128: Norway OTC healthcare new product launches (reports), by ingredients (top 10 ingredients), 2008 178 Table 129: Norway OTC healthcare new product launches (reports), by package tags or claims 2008 179 Table 130: Norway OTC healthcare new product launches, 2008 179 Table 131: Norway population, by age group, 2003?08 (millions) 180 Table 132: Norway population forecast, by age group, 2008?13 (millions) 181 Table 133: Norway population, by gender, 2003?08 (millions) 181 Table 134: Norway population forecast, by gender, 2008?13 (millions) 182 Table 135: Norway nominal GDP, 2003?08 (NOKbn, nominal prices) 182 Table 136: Norway nominal GDP forecast, 2008?13 (NOKbn, nominal prices) 182 Table 137: Norway real GDP, 2003?08 (NOKbn, 2000 prices) 183 Table 138: Norway real GDP forecast, 2008?13 (NOKbn, 2000 prices) 183 Table 139: Norway real GDP, 2003?08 ($bn, 2000 prices) 183 Table 140: Norway real GDP forecast, 2008?13 ($bn, 2000 prices) 184 Table 141: Norway consumer price index, 2003?08 (2000=100) 184 Table 142: Norway consumer price index, 2008?13 (2000=100) 184 [Inhaltsverzeichnis ausblenden] |
||||||||||||
| Hinweis: | * Der Rechnungsbetrag für diese Studie wird in $ (Dollar) ausgewiesen. Kunden aus dem Inland bekommen von uns eine Rechnung in Euro, umgerechnet zum letztwöchigen Schlusskurs | |||||||||||
|
|
||||||||||||


